Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denufosol mucociliary clearance in cystic fibrosis
NCT00425165Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Aug 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of denufosol tetrasodium in cystic fibrosis (CF), sponsored by Merck & Co.. Started Aug 2007; status: terminated.
02
Drugs
denufosol tetrasodium
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00425165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425165.